OBJECTIVE: To evaluate the relative merits of viability and ischaemia for prognosis after revascularisation. METHODS: Low-high dose dobutamine stress echocardiography (DSE) was performed before revascularisation in 128 consecutive patients with ischaemic cardiomyopathy (mean (SD) left ventricular ejection fraction (LVEF) 31 (8)%). Viability (defined as contractile reserve (CR)) and ischaemia were assessed during low and high dose dobutamine infusion, respectively. Cardiac death was evaluated during a five year follow up. Clinical, angiographic, and echocardiographic data were analysed to identify predictors of events. RESULTS: Univariable predictors of cardiac death were the presence of multivessel disease (hazard ratio (HR) 0.21, p < 0.001), baseline LVEF (HR 0.90, p < 0.0001), wall motion score index (WMSI) at rest (HR 4.02, p = 0.0006), low dose DSE (HR 7.01, p < 0.0001), peak dose DSE (HR 4.62, p < 0.0001), the extent of scar (HR 1.39, p < 0.0001), and the presence of CR in > or = 25% of dysfunctional segments (HR 0.34, p = 0.02). The best multivariable model to predict cardiac death included the presence of multivessel disease, WMSI at low dose DSE, and the presence of CR in > or = 25% of the severely dysfunctional segments (HR 9.62, p < 0.0001). Inclusion of ischaemia in the model did not provide additional predictive value. CONCLUSION: The findings of the present study illustrate that in patients with ischaemic cardiomyopathy, the extent of viability (CR) is a strong predictor of long term prognosis after revascularisation. Ischaemia did not add significantly in predicting outcome.
OBJECTIVE: To evaluate the relative merits of viability and ischaemia for prognosis after revascularisation. METHODS: Low-high dose dobutamine stress echocardiography (DSE) was performed before revascularisation in 128 consecutive patients with ischaemic cardiomyopathy (mean (SD) left ventricular ejection fraction (LVEF) 31 (8)%). Viability (defined as contractile reserve (CR)) and ischaemia were assessed during low and high dose dobutamine infusion, respectively. Cardiac death was evaluated during a five year follow up. Clinical, angiographic, and echocardiographic data were analysed to identify predictors of events. RESULTS: Univariable predictors of cardiac death were the presence of multivessel disease (hazard ratio (HR) 0.21, p < 0.001), baseline LVEF (HR 0.90, p < 0.0001), wall motion score index (WMSI) at rest (HR 4.02, p = 0.0006), low dose DSE (HR 7.01, p < 0.0001), peak dose DSE (HR 4.62, p < 0.0001), the extent of scar (HR 1.39, p < 0.0001), and the presence of CR in > or = 25% of dysfunctional segments (HR 0.34, p = 0.02). The best multivariable model to predict cardiac death included the presence of multivessel disease, WMSI at low dose DSE, and the presence of CR in > or = 25% of the severely dysfunctional segments (HR 9.62, p < 0.0001). Inclusion of ischaemia in the model did not provide additional predictive value. CONCLUSION: The findings of the present study illustrate that in patients with ischaemic cardiomyopathy, the extent of viability (CR) is a strong predictor of long term prognosis after revascularisation. Ischaemia did not add significantly in predicting outcome.
Authors: R Sicari; A Ripoli; E Picano; A C Borges; A Varga; W Mathias; L Cortigiani; R Bigi; J Heyman; S Polimeno; O Silvestri; V Gimenez; P Caso; S Severino; A Djordjevic-Dikic; M Ostojic; C Baldi; G Seveso; N Petix Journal: Eur Heart J Date: 2001-05 Impact factor: 29.983
Authors: F Jamal; J Strotmann; F Weidemann; T Kukulski; J D'hooge; B Bijnens; F Van de Werf; I De Scheerder; G R Sutherland Journal: Circulation Date: 2001-08-28 Impact factor: 29.690
Authors: E Picano; R Sicari; P Landi; L Cortigiani; R Bigi; C Coletta; A Galati; J Heyman; R Mattioli; M Previtali; W Mathias; C Dodi; G Minardi; J Lowenstein; G Seveso; A Pingitore; A Salustri; M Raciti Journal: Circulation Date: 1998-09-15 Impact factor: 29.690
Authors: J J Bax; D Poldermans; A Elhendy; J H Cornel; E Boersma; R Rambaldi; J R Roelandt; P M Fioretti Journal: J Am Coll Cardiol Date: 1999-07 Impact factor: 24.094
Authors: Timothy F Christian; Mei Lee Frankish; Jennifer H Sisemoore; Madeline R Christian; George Gentchos; Stephen P Bell; Michael Jerosch-Herold Journal: J Nucl Cardiol Date: 2010-05-15 Impact factor: 5.952
Authors: S Bisplinghoff; C Hänisch; M Becker; K Radermacher; M de la Fuente Journal: Int J Comput Assist Radiol Surg Date: 2014-05-10 Impact factor: 2.924
Authors: Julio A Panza; Thomas A Holly; Federico M Asch; Lilin She; Patricia A Pellikka; Eric J Velazquez; Kerry L Lee; Salvador Borges-Neto; Pedro S Farsky; Robert H Jones; Daniel S Berman; Robert O Bonow Journal: J Am Coll Cardiol Date: 2013-03-07 Impact factor: 24.094
Authors: Jamie M O'Driscoll; Paula Gargallo-Fernandez; Marco Araco; Manuel Perez-Lopez; Rajan Sharma Journal: Int J Cardiovasc Imaging Date: 2017-07-06 Impact factor: 2.357